All In Biotech

Drug Trial Radar · NCT03523962

Pre-operative Alcohol Skin Solutions in Fractured Extremities

PREPARE: A Pragmatic Randomized Trial Evaluating Pre-operative Alcohol Skin Solutions in FRactured Extremites

Last checked: Nov 19, 2026Latest source record: Oct 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 8,485 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,485

Actual

Start

Aug 21, 2018

Primary completion

Mar 15, 2023

Study completion Feb 2, 2024

Sponsor

Lead sponsor
University of Maryland, BaltimoreAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
McMaster University; Patient-Centered Outcomes Research Institute
First posted
May 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The prevention of infection is an important goal influencing peri-operative care of extremity fracture patients. Standard practice in the operative management of extremity fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for extremity fracture surgery.

Conditions

  • Surgical Site Infection
  • Unplanned Fracture-Related Reoperation
  • Open Appendicular Fracture
  • Closed Lower Extremity Fracture
  • Pelvic Fracture

Interventions

  • DuraPrepDrug

    The iodine-based treatment intervention is an antiseptic solution comprised of iodine povacrylex (0.7% free iodine) in 74% isopropyl alcohol. 3M™ DuraPrep™ \[3M Health Care, St Paul, MN\], will be the commercial product used.

  • ChloraPrepDrug

    The CHG intervention is an antiseptic solution comprised of 2% CHG in 70% isopropyl alcohol. ChloraPrep® \[CareFusion Inc., Leawood, KS, USA\] will be the product used.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With a Superficial Incisional Surgical Site Infection (SSI)Time frame: Within 30 days of the patient's last planned fracture management surgery
  2. Number of Participants With a Deep Incisional InfectionTime frame: Within 90 days of the patient's last planned fracture management surgery

Locations

27 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, Irvine

    Irvine, California

  • Cedars Sinai

    Los Angeles, California

  • Regional Medical Center of San Jose

    San Jose, California

  • Indiana University Health Methodist Hospital

    Indianapolis, Indiana

  • Louisiana State University

    Baton Rouge, Louisiana

  • University of Maryland, R Adams Cowley Shock Trauma Center

    Baltimore, Maryland

  • University of Maryland Capital Region Health

    Cheverly, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Bryan Health

    Lincoln, Nebraska

  • Dartmouth-Hitchcock Medical Center

    Hanover, New Hampshire

  • Carolinas Medical Center, Atrium Health Musculoskeletal Institute

    Charlotte, North Carolina

  • Duke University Hospital

    Durham, North Carolina

  • Wake Forest Baptist University Medical Center

    Winston-Salem, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Case Western / MetroHealth Medical Center

    Cleveland, Ohio

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Greenville Health System

    Greenville, South Carolina

  • Sanford Health

    Sioux Falls, South Dakota

  • San Antonio Military Medical Center

    San Antonio, Texas

  • University of Utah

    Salt Lake City, Utah

  • Inova Health System Foundation / Inova Fairfax Hospital

    Falls Church, Virginia

  • University of Wisconsin

    Madison, Wisconsin

  • Royal Columbia Hospital

    New Westminster, British Columbia, Canada

  • Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • McMaster University, Center for Evidence-Based Orthopaedics

    Hamilton, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.